Patogeneza, diagnostyka i leczenie nawracajacej obturacji drog oddechowych koni

• Autorzy: Niedzwiedz A , Nicpon J. , Rozycki P.

Warianty tytułu

EN

Pathogenesis, diagnosis and treatment of Recurrent Equine Airway Obstruction

• Języki publikacji: PL

Abstrakty

EN

Equine Recurrent Airway Obstruction (RAO), also known as heaves or broken wind, is one of the most common ailments of middle-aged horses. Inflammation of the airways is induced by organic dust exposure. This illness is characterized by neutrophilic inflammation, bronchospasm, excessive mucus production and pathologic changes in the bronchiolar walls. Clinical signs resolve themselves within 3-4 weeks after the animals undergo environmental change. Horses suffering from RAO are susceptible to allergens throughout their lives, and should therefore be properly managed. The most important aspect of therapy is to eliminate dust exposure, the administration of corticosteroids and the of use bronchodilators to improve pulmonary function.

Słowa kluczowe

PL

patogeneza; leczenie; diagnostyka; nawracajaca obturacja drog oddechowych; choroby zwierzat; konie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 05
• Opis fizyczny: s.512-515,bibliogr.

Twórcy

autor

Niedzwiedz A

• Akademia Rolnicza, pl.Grunwaldzki 47, 50-366 Wroclaw

autor

Nicpon J.

autor

Rozycki P.

Bibliografia

• 1. Amman V. J., Lavoie J. P., Vrins A. A.: Effects of beclomethasone dipropionate in horses with chronic obstructive pulmonary disease (COPD). Proc. 13th Ann. Med. Forum ACVIM. 1995, 13th, 1037.
• 2. Bailey J., Colahan P., Kubilis P.: Effect of inhaled beta2-adrenoreceptors agonists, albuterol sulfate on performance of horses. Equine Vet. J. Suppl. 1999, 30, 575-580.
• 3. Barnes P. J.: Molecular mechanisms of glucocorticoid action in asthma.: Pulm. Pharmacol. Ther. 1997, 10, 3-19.
• 4. Bureau F., Bonizzi G., Kirschvink N., Delhalle S., Desmecht D., Merville M. P., Bours V., Lekeux P.: Correlation between nuclear factor-kB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am. J. Respir. crit. care Med. 2000, 161, 1314-1321.
• 5. Davis E., Rush B. R.: Equine recurrent airway obstruction: pathogenesis, diagnosis and patient management. Vet. Clin. North Am. Equine Pract. 2002, 18, 453-467.
• 6. Dixon P. M., Railton D. I., McGorum B. C.: Equine pulmonary disease: a case control study of 300 reffered cases: part 2. Details of animals and of historical and clinical findings. Equine Vet. J. 1995, 27, 422-427.
• 7. Dixon P. M., Railton D. I., McGorum B. C.: Equine pulmonary disease: a case control study of 300 reffered cases: part 3. Ancillary diagnostics findings. Equine Vet. J. 1995, 27, 428-435.
• 8. Durchame N. G., Fubini S. L.: Gastrointestinal complications associated with the use of atropine in horses. J. Am. Vet. Med. Assoc. 1983, 182, 229-231.
• 9. Duvivier D. H., Bayly W. M., Votion D., Vandenput S., Farnir F., Lekeux P.: Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD. Equine Vet. J. 1999, 31, 20-24.
• 10. Duvivier D. H., Votion D., Vandenput S., Art T., Lekeux P.: Airway response of horses with COPD to dry powder inhalation of ipratropium bromide. Vet. J. 1997, 154, 149-153.
• 11. Henrikson S. L., Rush B. R.: Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. J. Am. Vet. Med. Assoc. 2001, 218, 1961-1965.
• 12. Hoffman A.: Inhaled medications and bronhodilator use in the horse. Vet. Clin. North Am. Equine Pract. 1997, 13, 519-530.
• 13. Horohov D. W.: Equine T-cell cytokines: protection and pathology. Vet. Clin. North Am. Equine Pract. 2000, 16, 1-4.
• 14. Jackson C. A., Berney C., Jefcoat A. M., Robinson N. E.: Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine Vet. J. 2000, 32, 432-438.
• 15. Jackson C. A., Robinson N. E., Berney C. E. A., Jefcoat A. M., Derksen F. J.: Prednisone-is it really effective in the treatment of chronic obstructive pulmonary disease? Proceedings of the 45th Annual AAEP Convention. 1999, 304-305.
• 16. Jefcoat A. M., Hotchkiss J. A., Harkema J. R., Basbaum C. B., Robinson N. E.: Persistent mucin glycoprotein alterations in equine recurrent airway obstruction. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281, L704-L712.
• 17. LaPointe J. M., Lavoie J. P., Vrins A. A.: Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am. J. Vet. Res. 1993, 54, 1310-1316.
• 18. Lavoie J. P.: Update on equine therapeutics: inhalation therapy for equine heaves. Compend. Contin. Educ. Pract. Vet. 2001, 23, 475-477.
• 19. Leguillette R.: Recurrent airway obstructon-heaves. Vet. Clin. North Am. Equine Pract. 2003, 19, 63-86.
• 20. McGorum B. C., Dixon P. M., Halliwel R. E.: Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Vet. J. 1993, 25, 261-267.
• 21. McPherson E. A., Lawson G. H., Murphy J. R., Nicholson J. M., Fraser J. A., Breeze R. G., Pirine H. M.: Chronic obstructive pulmonary disease (COPD): identification of affected horses. Equine Vet. J. 1978, 10, 47-53.
• 22. Nyman G., Lindberg R., Weckner D., Bjork M., Kvartc C., Persson S. G., Gustafsson H., Hendenstierna G.: Pulmonary gas exchange correlated to clinical signs and lung pathology in horses with chronic bronchiolitis. Equine Vet. J. 1991, 23, 253-260.
• 23. Robinson N. E.: International Workshop on equine chronic airway disease. Equine Vet. J. 2001, 33, 5-19.
• 24. Robinson N. E., Jackson C., Jefcoat A., Berney C., Peroni D., Derksen F. J.: Efficacy of three corticosteroids for the treatment of recurrent airway obstruction (heaves). Equine Vet. J. 2002, 34, 17-22.
• 25. Robinson N. E.: Recurrent airway obstruction (Heaves). International Veterinary Information Service, Ithaca NY. 2001, B0317.1101.
• 26. Rush B. R., Raub E. S., Rhoads W. S., Flaminco M. J., Matson C. J., Hakala J. E., Gillespie J. R.: Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. Vet. Res. 1998, 59, 1039-1043.
• 27. Seahorn T. L., Beadle R. E.: Summer pasture-associated obstructive pulmonary disease in horses: 21 cases (1983-1991). J. Am. Vet. Med. Assoc. 1993, 202, 779-782.
• 28. Seahorn T. L., Groves M. G., Harrington K. S., Beadle R. E.: Chronic obstructive pulmonary disease in horses in Louisiana. J. Am. Vet. Med. Assoc. 1996, 208, 248-251.
• 29. Tasche M. J., Uijen J. H., Bernsen R. M., de Jongste J. C., van der Wouden J. C.: Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax. 2000, 55, 913-920.
• 30. Tesarowski D. B., Viel L., McDonell W. N.: Pulmonary function measurements during repeated environmental challenge of horses with recurrent airway obstruction (heaves). Am. J. Vet. Res. 1996, 57, 1214-1219.
• 31. Thomson J. R., McPherson E. A.: Chronic obstructive pulmonary disease in the horse. Part 2: Therapy. Equine Vet. J. 1983, 15, 207-210.
• 32. Thomson J. R., McPherson E. A.: Effects of environmental contron on pulmonary function of horses affected with chronic obstructive pulmonary disease. Equine Vet. J. 1984, 16, 35-38.
• 33. Thomson J. R., McPherson E. A.: Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horse. Equine Vet. J. 1981, 13, 243-246.
• 34. Vandenput S., Istasse L., Nicks B., Leukeux P.: Airborne dust and aeroallergen concentrations in different sources of feed and bedding for horses. Vet. Quarterly. 1997, 19, 154-158.
• 35. Watson E. D., Sweeney C. R., Steensma K. A.: Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD. Equine Vet. J. 1992, 24, 379-381.
• 36. Woods P. S., Robinson N. E., Swanson M. C., Reed C. E., Broadstone R. V., Derksen F. J.: Airborne dust and aeroallergen concentration in a horse stable under two different management systems. Equine Vet. J. 1993, 25, 208-213.